{"id":16487,"date":"2024-04-24T06:18:03","date_gmt":"2024-04-23T20:18:03","guid":{"rendered":"https:\/\/doseme-rx.com\/?p=16487"},"modified":"2025-01-22T06:15:31","modified_gmt":"2025-01-21T20:15:31","slug":"dr-howard-mcleod-joins-doseme-clinical-advisory-boar","status":"publish","type":"post","link":"https:\/\/doseme-rx.com\/fr\/news-media\/article\/dr-howard-mcleod-joins-doseme-clinical-advisory-boar","title":{"rendered":"Industry Veteran Dr. Howard McLeod Joins the DoseMe Clinical Advisory Board"},"content":{"rendered":"\n

The Clinical Advisory Board (CAB) is a group of prestigious experts advising DoseMe in the pursuit of clinical excellence and governance and we are thrilled to add Dr. Howard McLeod, FASCO, FCCP.<\/em><\/p>\n\n\n\n

April 23, 2024<\/p>\n\n\n\n

Dr. Howard McLeod<\/a> is an internationally recognized expert in precision medicine, having made novel contributions at the discovery, translation, implementation, and policy levels. He is the Director and Professor at the Utah Tech University Center for Precision Medicine and Functional Genomics and a Precision Medicine Advisor at the Geriatric Oncology Consortium.<\/p>\n\n\n\n

\u201cThere have been great strides in some areas of precision medicine, but there needs to be a massive change in culture. I am thrilled to join the CAB as I believe dosing is one of the top priorities for standardized practices,\u201d commented McLeod. \u201cI share DoseMe\u2019s vision and passion to bring precision dosing to the forefront of clinical practice and drug development and I look forward to collaborating with some of the best minds in the industry.\u201d<\/p>\n\n\n\n

Dr. McLeod has implemented or advised implementation of precision medicine at integrated health systems, academic medical centers, and community practices around the world. Dr. McLeod was a recent member of both the FDA committee on Clinical Pharmacology and the NIH Human Genome Advisory Council. Howard has published over 600 peer reviewed papers on precision medicine, pharmacogenomics, and clinical pharmacology and continues to work to advance innovative healthcare. <\/p>\n\n\n\n

\u201cHoward brings a wealth of knowledge that is invaluable, we are incredibly privileged to welcome him aboard,\u201d Sharmeen Roy, Chief Strategy and Science Officer at DoseMe. \u201cOn a personal note, I find Howard\u2019s clinical acumen and visionary approach to precision medicine truly inspiring. His involvement is sure to shape our product\u2019s trajectory and spur the critical shift toward precision dosing in healthcare.\u201d<\/p>\n\n\n\n

Dr. McLeod has been recognized as a Fellow of both the American Society of Clinical Oncology and the American College of Clinical Pharmacy. He has also been an active Board Member and\/or Founder for over a dozen privately held and publicly traded companies.<\/p>\n\n\n\n

\u201cAreas of infectious disease have recognized the benefits of dosing with efficacy and minimizing toxicity events, but we can do better,\u201d states McLeod.<\/p>\n\n\n

\r\n \r\n
\r\n\t

Demandez une d\u00e9mo<\/h2>\r\n\t

D\u00e9couvrez \u00e0 quel point DoseMeRx est facile \u00e0 utiliser et \u00e0 int\u00e9grer dans votre journ\u00e9e de travail.<\/p>\n

Demandez une d\u00e9mo ci-dessous. Vous pouvez \u00e9galement nous appeler au +1 (832) 358-3308 ou nous envoyer un e-mail \u00e0 hello@dosemehealth.com<\/a><\/p>\n<\/div>\t\t\r\n\r\n